Contact this trialFirst, we need to learn more about you.
Selpercatinib for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 3
Jacksonville, Florida
This trial is testing a new drug to see if it can prevent cancer from returning in people who have had surgery or radiation for early-stage lung cancer. It will last up to three years, and people whose cancer comes back while taking the placebo will be able to switch to the new drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.